Authorisation granted for use of bis(2-methoxyethyl) ether (diglyme)
The European Commission has granted an <link https: eur-lex.europa.eu legal-content en txt pdf _blank>authorisation for one use of bis(2-methoxyethyl) ether (diglyme) by the Merck KGaA. The review period will expire on 27 June 2030.